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Recent studies have shown that defined factors
could lead to the direct conversion of fibroblasts
into induced hepatocyte-like cells (iHeps). However,
reported conversion efficiencies are very low, and
the underlying mechanism of the direct hepatic re-
programming is largely unknown. Here, we report
that direct conversion into iHeps is a stepwise transi-
tion involving the erasure of somatic memory,
mesenchymal-to-epithelial transition, and induction
of hepatic cell fate in a sequential manner. Through
screening for additional factors that could potentially
enhance the conversion kinetics, we have found that
c-Myc and Klf4 (CK) dramatically accelerate conver-
sion kinetics, resulting in remarkably improved iHep
generation. Furthermore, we identified small mole-
cules that could lead to the robust generation of
iHeps without CK. Finally, we show that Hnf1a sup-
ported by small molecules is sufficient to efficiently
induce direct hepatic reprogramming. This approach
might help to fully elucidate the direct conversion
process and also facilitate the translation of iHep
into the clinic.
INTRODUCTION
Although derivatives of induced pluripotent stem cells (iPSCs)
hold great potential for clinical applications, the risk for tumor for-814 Cell Reports 15, 814–829, April 26, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://mation upon their transplantation into patients, due to possible
contamination with residual undifferentiated cells, may limit their
therapeutic potential (Tang et al., 2011). Recently, transcription-
factor-mediated direct conversion technology has been devel-
oped to overcome tumor-forming issues associated with the
current iPSC technology (Caiazzo et al., 2011; Ginsberg et al.,
2012; Han et al., 2011, 2012; Ieda et al., 2010; Kim et al., 2014;
Pang et al., 2011; Pfisterer et al., 2011; Szabo et al., 2010; Vier-
buchen et al., 2010). Furthermore, this technology represents a
relatively simpler and faster procedure than iPSC technology,
wherein multiple steps, such as iPSC generation, differentiation
into desired cell types, and purification of differentiated cell
types, are essentially required. Indeed, the generation of cardio-
myocytes or neurons using iPSC technology typically takes
4–6 weeks—at least 2 weeks for generating iPSCs with 0.02%
reprogramming efficiency (Takahashi et al., 2007; Takahashi
and Yamanaka, 2006) and another 2–4 weeks for differentiating
iPSCs into cardiomyocytes or neurons (Bibel et al., 2004; Lian
et al., 2013). In contrast, direct conversion technology takes
only 1 week, with 9% and 20% efficiency to obtain cardiomyo-
cytes and neurons, respectively (Song et al., 2012; Vierbuchen
et al., 2010), indicating that direct conversion technology can
be used to readily obtain a sufficient number of target cells for
both mechanistic and clinical studies.
Previous studies have also demonstrated that fibroblasts can
be directly converted into cells resembling functional hepato-
cytes—namely, induced hepatocyte-like cells (iHeps)—by
defined sets of transcription factors (Huang et al., 2011; Sekiya
and Suzuki, 2011). Specifically, Sekiya and Suzuki (2011) have
identified three combinations (Hnf4a/Foxa1, Hnf4a/Foxa2, or
Hnf4a/Foxa3) that could induce a hepatocyte-like state fromcreativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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mouse embryonic fibroblasts (MEFs). Simultaneously, Huang
et al., (2011) have reported that ectopic expression of three he-
patic factors (Hnf1a/Foxa3/Gata4), together with inactivation of
p19Arf, could also directly convert fibroblasts into expandable
and functional iHeps. More recently, ectopic expression of
Foxa3 and Hnf1b has been described to lead to the conversion
of the fibroblasts into bipotent induced hepatic stem cells
(iHepSCs) (Yu et al., 2013). Although the iHeps and iHepSCs
closely resemble their in vivo counterparts in a number of char-
acteristics (Kim et al., 2015; Yu et al., 2013), the low efficiency
and slow kinetics of the direct conversion process—at least 2
to 3 weeks for obtaining iHeps and iHepSCs with less than 1%
conversion efficiency—may pose major limitations to their trans-
lational utility. Furthermore, the molecular mechanisms underly-
ing the direct conversion process remain unknown.
In the present study, we have (1) deciphered the direct conver-
sion kinetics toward the hepatic lineage, (2) screened for addi-
tional factors that could enhance hepatic lineage conversion,
and (3) uncovered the molecular mechanisms underlying the
conversion process by modulating the kinetics of direct hepatic
reprogramming. Here, we describe that direct conversion of fi-
broblasts into iHeps is a stepwise transition process involving
the erasure of somatic memory, mesenchymal-to-epithelial tran-
sition (MET), and acquisition of hepatic properties in a sequential
manner. Through screening for additional factors that could
enhance the delayed kinetics of both the MET and hepatic pro-
grams, we found that c-Myc and Klf4 (CK) accelerate the
sequential cell-fate transition, resulting in dramatically improved
iHep generation. Furthermore, we could replace CK with small
molecules in the generation of mouse and human iHeps, with
accelerated direct conversion kinetics as well as improved con-
version efficiency. Finally, we show that a single factor suffi-
ciently enables us to elicit direct conversion into mature iHeps
from mouse fibroblasts with high yield by using our defined
small-molecule combination.
RESULTS
DirectConversion of Fibroblasts into iHeps Is a Stepwise
Transition
Although previous studies thoroughly demonstrated that defined
hepatic factors could lead to the direct conversion of fibroblasts
into iHeps (Huang et al., 2011; Sekiya and Suzuki, 2011), the
molecular mechanisms governing the conversion process re-
mained largely unknown. To elucidate the underlying mecha-
nisms, we first deciphered the kinetics of the direct hepatic
reprogramming. To this end, MEFs that were free of potentiallyFigure 1. Direct Conversion of Fibroblasts into iHeps Is a Stepwise Tra
(A) Schematic diagram depicting the procedure for the direct conversion of fibro
early phases of the conversion process using qPCR and ChIP.
(B–D) Expression of fibroblast markers (B), MET-related genes (C), and hepatocyte
9 after transduction with reprogramming factors. Expression levels are normalize
(E) Summary of the time-course analysis describing the direct conversion kinetic
(F–H) ChIP analysis was carried out in a time-course manner (days 0, 10, and 15) fo
MET-related genes (G), and hepatocyte markers (H). rDNA-IGS2 was used to no
Error bars indicate the SD of triplicate values. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S2.
816 Cell Reports 15, 814–829, April 26, 2016contaminating epithelial cells (Figure S1A) were transduced
with retroviruses containing either Hnf4a/Foxa1 (4a1) or Hnf4a/
Foxa3 (4a3), as previously identified (Sekiya and Suzuki, 2011)
(Figure 1A). The direct conversion kinetics were assessed by
performing a time-course gene expression analysis of represen-
tative markers related to the fibroblast program, MET process,
and hepatic specification program during the early phase of
the lineage transition (days 3, 6, and 9) (Figure 1A). A qPCR anal-
ysis showed that the fibroblast markers began to be gradually
downregulated from day 3 onward (Figure 1B). Furthermore,
we observed the modest upregulation of MET-related genes
from day 6 onward, but mostly on day 9 (Figure 1C). Notably,
the activation of the hepatic program was much more delayed
than the loss of fibroblast markers or the activation of MET-
related genes (Figure 1D). Among the hepatocyte markers,
only Foxa2 and Hnf4a were found to be upregulated on day 9;
c-Met, Hnf1a, and Ttr were still transcriptionally repressed (Fig-
ure 1D). Taken together, these results indicate that the direct
conversion of fibroblasts toward iHeps involves a stepwise tran-
sition where three major events, ‘‘fibroblast program turn-off (on
days 3 to 6),’’ ‘‘MET program turn-on (on days 6 to 9),’’ and ‘‘he-
patic program turn-on (from day 9 onward),’’ occur sequentially
(Figure 1E).
MET Factors Accelerate Direct Conversion Kinetics
Given that the activation of the hepatic programwas delayed and
partially activated at a relatively late stage (day 9), we speculated
that additional hepatic factorsmay boost the activation of the he-
patic program. To this end, we screened five additional hepatic
factors on the basis of their known roles either in liver develop-
ment (Foxa2 and Gata4) (Lee et al., 2005; Watt et al., 2007) or
in the maintenance of liver functions (Cebpa, Oc1, and Dbp)
(Lavery et al., 1999; Wang et al., 1995). However, none of them
significantly boosted the slow conversion kinetics (Figure S2A).
Moreover, transducing MEFs with all the additional factors,
together with 4a3, did not have a beneficial effect on the conver-
sion kinetics or on the efficiency of iHep generation (data not
shown).
The MET, a reversible developmental process, is a prerequi-
site for pluripotential reprogramming (Li et al., 2010) and can
be promoted by the ectopic expression of CK through the inhibi-
tion of both the Tgfb1 and Tgfb2 receptors and the activation of
E-cadherin (Li et al., 2010). As the direct conversion of mesen-
chymal fibroblasts into hepatocytes, a type of epithelial cell,
may require the MET, we next attempted to enhance the MET
process, which was significantly more delayed than suppression
of the fibroblast program, by adding the MET activator CKnsition
blasts into iHeps as well as a time-course analysis of transduced MEFs at the
markers (D) was analyzed by qPCR in a time-coursemanner, on days 3, 6, and
d to those of MEFs.
s into a hepatic cell state.
r H3K4me3 and H3K27me3 on the regulatory regions of fibroblast markers (F),
rmalize the amount of precipitated DNA.
together with 4a3. In contrast to 4a3 alone, the fibroblast
markers appeared to be substantially downregulated on day 3
in the presence of CK (Figure 1B). Furthermore, activation of
the MET program was significantly enhanced in the presence
of CK, as the MET-related genes began to be upregulated on
day 6 and dramatically upregulated on day 9 with 4a3CK (Fig-
ure 1C). Surprisingly, the delayed activation of the hepatic pro-
gram was also accelerated in the presence of CK. Indeed,
among the hepatocyte markers,Hnf4a, amaster regulator of he-
patocytes, was dramatically activated at day 6, and the other he-
patocyte markers such as Foxa2,Hnf1a, c-Met, and Ttr, became
modestly activated at day 9 in the presence of CK (Figure 1D).
Similar results were obtained with a different combination,
4a1CK (Figure S2B). In the line with a previous study (Li et al.,
2010), CK alone could somewhat suppress the expression of
fibroblast markers. However, both the hepatic- and MET-related
genes were not activated (Figure S2C) with CK alone, indicating
that CK could play their assistant role in hepatic conversion only
in the presence of other hepatic factors such as 4a3. Considering
the significantly delayed kinetics of both theMET and the hepatic
program in 4a3-transduced MEFs, our data show that CK not
only induced a faster MET process but also accelerated the
entire direct conversion kinetics toward a hepatocyte-like state,
including fibroblast program turn-off and hepatic program turn-
on (Figure 1E).
To confirm the effect of CK at the epigenetic level, we per-
formed chromatin immunoprecipitation (ChIP) and qPCR to
quantify the occupancy of the ‘‘active’’ histone H3 lysine 4 trime-
thylation mark (H3K4me3) and ‘‘repressive’’ histone H4 lysine 27
trimethylation mark (H3K27me3) on the regulatory regions of
relevant genes. In the line with gene expression profiling (Fig-
ure 1B), the level of the H3K4me3 on the regulatory regions
of fibroblast markers was substantially reduced, but the
H3K27me3 level was dramatically increased in the presence of
CK (Figure 1F). 4a3CK-transduced MEFs also exhibited the
increased levels of H3K4me3 but reduced H3K27me3 levels on
the regulatory regions of MET and hepatocyte markers (Figures
1G and 1H). Overall, these data show that the somatic-, MET-,
and hepatic-related genes in the transduced MEFs were reprog-
rammed, even at the epigenetic levels, along with changes in
cell-type-specific gene expression. Therefore, the direct conver-
sion toward the hepatic lineage is based on sequential molecular
events, in which different epigenetic machineries are systemati-
cally controlled. This sequential procedure could be accelerated
in the presence of additional MET activators, such as CK, but not
additional hepatic cell factors.
Activation of MET Strongly Enhances the Efficiency of
iHep Generation
Next, we asked whether the accelerated direct conversion ki-
netics with CK may also improve the efficiency of iHep genera-
tion (Figure 1A; Experimental Procedures). We first monitored
transduction efficiency by both immunostaining for the individual
factors andmeasuring the induction level of transgenes by qPCR
(Figures S3A and S3B). We observed that 49%–91% of cells
were infected with each individual factor, indicating that about
25% of cells were infected with all the transgenes. When we
counted the number of colonies displaying epithelial cellmorphology in a time-course manner, particularly at early time
points (days 5, 7, and 10), we did not observe any epithelial col-
onies in the previously defined combinations (4a1 and 4a3) on
day 5 post-infection, and we observed only a small number of
epithelial colonies on days 7 and 10 (Figure 2A; Figure S3C). In
contrast, we observed more than 30 colonies on day 5, with a
continuous increase in the number of colonies until day 10 in
both 4a1CK and 4a3CK, indicating that the direct conversion
was enhanced in the presence of the additional MET activators,
CK (Figures 2A and S3C). Immunofluorescence analysis also re-
vealed that the number of E-cadherin-positive colonies was
dramatically increased in the presence of CK (Figures 2B and
2C). Furthermore, we were able to observe the constantly
increased numbers of both a-1 antitrypsin (Aat)- and albumin
(Alb)-positive colonies in the presence of CK (Figures 2D and
2E). Indeed, the number of Aat-positive colonies were increased
to a maximum 94.0-fold in the presence of CK (94.0-fold in
4a1CK and 63.9-fold in 4a3CK), and the number of Alb-positive
colonies were also enhanced 33- to 48-fold (33.0-fold in
4a1CK and 48.3-fold in 4a3CK). Notably, the combination of
4a3CK led to the most efficient reprogramming of fibroblasts to-
ward iHeps. Taken together, our data indicate that the additional
CK dramatically improve the efficiency of iHep generation.
Although only a few epithelial colonies appeared in MEFs in-
fected with CK only (Figures 2A and 2B), they were completely
Aat and Alb negative and did not exhibit any hepatic cell prop-
erties (data not shown). Furthermore, transduction with a single
factor, either c-Myc (C) or Klf4 (K), together with the combina-
tion 4a1 or 4a3 failed to increase the number of epithelial col-
onies (Figure S3D), although the proliferation of MEFs was
accelerated in the presence of C or CK but not with K alone
(Figure S3E). Considering the enhanced iHep generation in
the presence of CK but not C or K alone, our data clearly indi-
cate that the enhanced iHep generation by CK is not simply
due to the increased proliferation of initial iHeps but rather
due to the activation of MET process; therefore, a cooperative
action of C and K is essential for achieving a high conversion
efficiency.
iHeps Represent Functional Hepatic Cells
Established iHep lines exhibited morphology similar to and gene
expression hallmarks of primary hepatocytes (Figures S1A–
S1C), without expressing other primitive endoderm or foregut
endoderm progenitor markers, suggesting that they are directly
converted from fibroblasts without first passing through an
endodermal progenitor cell state (Figures S1D–S1H). They
were stably expandable in vitro with normal karyotypes, even
in the absence of transgenes (Figures S1I–S1P). As in primary
hepatocytes, the hepatocyte markers Alb, CK18, Cyp1a2,
E-cadherin, and ZO-1 were expressed in both 4a1CK and
4a3CK iHeps as determined by immunostaining (Figure 3A).
On the other hand, Vimentin, a fibroblast marker was not de-
tected in all iHeps (Figure 3A). Furthermore, a series of points
of evidence—including urea production, Alb secretion, expres-
sion of liver-specific enzymes, and other in vitro functional ana-
lyses—indicates that all iHep lines (4a3, 4a1CK, and 4a3CK)
share important functional characteristics with primary hepato-
cytes (Figures 3B–3F and S4A–S4C). Taken together, theseCell Reports 15, 814–829, April 26, 2016 817
Figure 2. Activation of MET Enhances the Generation of iHeps
(A) The number of epithelial cell colony after transduction with different combinations of transcription factors. The number of epithelial cell colonieswas counted in
a time-course manner (the number of colonies on day 10, 4a1: 0.8 ± 0.2; 4a3: 1.0 ± 0.2; 4a1CK: 51.0 ± 7.1; 4a3CK: 69.0 ± 8.8).
(B and C) The number (B) and morphology (C) of E-cadherin-positive colonies on day 15 after transduction (4a1: 26.3 ± 3.5; 4a3: 71.3 ± 7.3; 4a1CK: 335.7 ± 34.4;
4a3CK: 580.0 ± 46.5). We split the cells twice in a 1:3 ratio on days 10 and 15 when they reached confluence and performed immunocytochemistry using an
antibody against E-cadherin. Scale bars represent 100 mm.
(D and E) The number of Aat-positive (D) and Alb-positive (E) colonies on days 5, 7, and 10 after transductions were counted. (Number of Aat-positive colonies on
day 10; 4a1: 0.9 ± 0.6; 4a3: 1.7 ± 0.6; 4a1CK: 65.7 ± 5.5; 4a3CK: 84.3 ± 8.3. Number of Alb-positive colonies on day 10; 4a1: 1.0 ± 0.8; 4a3: 1.2 ± 1.0; 4a1CK:
25.6 ± 4.1; 4a3CK: 45.0 ± 4.9). The cells were stained using antibodies against Aat and Alb.
Error bars indicate the SD of triplicate values. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S3C.data demonstrate that 4a1CK and 4a3CK iHeps share molecular
and functional characteristics with primary hepatocytes.
Next, we sought to analyze the global gene expression profiles
of 4a1CK and 4a3CK iHep lines for the purpose of evaluating the
reprogramming level of the entire transcriptome. Pearson corre-
lation analysis revealed that all iHep lines were clustered
together with primary hepatocytes (Figure 3G), indicating the818 Cell Reports 15, 814–829, April 26, 2016activation of the endogenous hepatic program in the iHep lines.
Furthermore, iHeps expressed a set of genes related to various
metabolic pathways and the MET process at levels similar, but
not identical, to those of primary hepatocytes (Figure S4D). We
further deciphered the global transcriptome of iHeps by
analyzing the reprogrammed and non-reprogrammed tran-
scripts (Figure S4E). We found that a number of genes related
(legend on next page)
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to liver development and the MET process were highly enriched
in the reprogrammed DEGs (differentially expressed genes),
such as DEG-1 and -2 (Figure S4F). Interestingly, a number of
genes related to cell cycle, cell division, and mitosis were highly
enriched in DEG-4, non-reprogrammed DEGs, explaining the
highly proliferative capacity of the established iHeps (Fig-
ure S4G). Taken together, our data indicate that the global
gene expression pattern of iHeps is similar to that of primary he-
patocytes, although not identical.
In Vivo Functional Characterizations of iHeps
To provide evidence for the in vivo functionality of iHeps, we
transplanted iHeps into a CCl4-induced acute liver failure model.
As acute centrilobular injury induced by CCl4 resolves within
7–10 days (Woo et al., 2012), we closely looked into the early
phase of liver repair after transplantation. Large necrotic lesions
were predominant in the liver of sham-operated mice but pro-
foundly reduced on day 3 post-transplantation (Figure 4A).
Furthermore, both GFP- and Alb-positive iHeps appeared to
be integrated into the liver parenchyma and were mostly distrib-
uted around central veins of the host injured liver (Figure 4B).
Importantly, transplantation of all iHep lines promoted the resto-
ration of sinusoidal vascular network (Figure 4C) and proliferation
of host hepatocytes (GFP/Edu+) (Figure 4G). Hepatic stellate
cells (HSCs) and liver resident macrophages—namely, Kupffer
cells—are critical hepatic non-parenchymal cells that play
important roles in the initial phase of liver regeneration (Michalo-
poulos and DeFrances, 1997). We also found that infiltration of
reactive HSCs (a-SMA) and macrophage (F4/80) was markedly
increased in the injury sites of the liver that received iHeps
compared with normal and sham-operated livers (Figures 4D
and 4E). Furthermore, fibrin clearance in the necrotic areas
was profoundly increased (Figure 4F), and both serum AST
(aspartate aminotransferase) and ALT (alanine aminotrans-
ferase) levels were significantly decreased (Figures 4H and 4I).
Collectively, these data suggest that directly converted iHeps
incorporate into the host liver and contribute to tissue recovery
after the acute liver injury.
Next, we investigated the in vivo functionality of iHeps in a
well-studied murine model of tyrosinemia type I, the fumarylace-
toacetate-hydrolase-deficient (FAH/) mice. These immunode-Figure 3. Characterization of the Established iHep Lines
(A) Immunofluorescencemicroscopy images of 4a1CK and 4a3CK iHep lines usin
of iHeps using antibodies against E-cadherin and ZO-1. MEFs and primary hep
staining revealed no contamination of the starting MEFs with preexisting epitheli
(B and C) Both urea production (B) and Alb secretion (C) were determined in 4a1CK
positive controls, respectively.
(D) Expression levels of Cyp450 enzymes in response to Cyp inducers (3-me
Expression levels are normalized to those of MEFs.
(E) The activity of Cyp1a2 in response to 200 mM of acetaminophen.
(F) In vitro functional analysis of iHeps including PAS (Periodic acid-Schiff) staini
poprotein (Ac-LDL) labeled with the fluorescent probe, DiI (DiI-conjugated Ac-LDL
as negative and positive controls, respectively.
(G) Heatmap representing the global gene expression profile of MEFs, iHeps (4a3
more than 2-fold differentially expressed between MEFs and primary hepatocyte
scale. Red and green represent higher and lower gene expression levels, respe
profiles from the heatmap is shown on the top of the heatmap.
Scale bars represent 100 mm. Error bars indicate the SD of triplicate values. *p <
See also Figures S4B–S4G.
820 Cell Reports 15, 814–829, April 26, 2016ficient FAH/-Rag2/-gc/ mice (FRG mice) have been used
for evaluating in vivo functionality of iHeps in previous studies
(Huang et al., 2011; Sekiya and Suzuki, 2011). One million 4a3
and 4a3CK iHeps, respectively, were transplanted into the liver
of FRG mice via intrasplenic injection, which allows for delivery
of the transplanted cells into the liver sinusoids via portal vein.
Interestingly, the group of 4a3CK iHep-transplanted mice
showed substantially prolonged survival, suggesting that the
functional iHeps were efficiently generated with the reprogram-
ming cocktail defined in the present study (Figure 4J). Taken
together, our data clearly suggest that the functionality of iHeps
generated in the present study is comparable to that of previ-
ously reported iHeps, although relatively limited compared to
that of primary hepatocytes.
Small Molecules Can Replace CK during the Direct
Conversion Process
Although the presence of the MET activators CK accelerated the
kinetics and, consequently, enhanced the efficiency of iHep gen-
eration, these two activators must be excluded from the direct
conversion cocktail for future clinical applications, due to their
oncogenic properties (Nakagawa et al., 2008). Thus, we attemp-
ted to identify small molecules that may facilitate the MET pro-
cess as a surrogate for CK in our iHep generation protocol.
A-83-01 (A), an inhibitor of Smad signaling, inhibits Tgfb-induced
epithelial-to-mesenchymal transition and, thus, facilitates the
MET process (Tojo et al., 2005), and CHIR99021, an inhibitor of
glycogen synthase kinase 3b (Gsk-3b), enhances iPSC genera-
tion by inducing rapid proliferation of somatic cells (Marson
et al., 2008). As both compounds can activate the MET (Li
et al., 2010) and induce the rapid proliferation (Li et al., 2009;
Marson et al., 2008; Ruiz et al., 2011) of starting cells, thereby
increasing the efficiency of iPSC generation, we hypothesized
that these inhibitors might also replace CK in the induction of he-
patic lineage conversion. Prior to replacing CK with these small
molecules, we tried to elucidate the effect of CK on both the
TGFb and Wnt signaling pathways (Figures S5A and S5B). In
the presence of hepatic factors (4a3), CK was able to not only
inhibit the TGFb pathway, as evidenced by the decreased fibro-
blast markers and increasedMET-related genes (Figure S5A) but
also activate Wnt targets (Figure S5B). Furthermore, by treatingg antibodies against Alb, CK18, and CYP1a2, and confocal microscopy images
atocytes were used as negative and positive controls, respectively. Vimentin
al cells.
and 4a3CK iHeps. MEFs and primary hepatocytes were used as negative and
thylcholanthrene, rifampicin, and dexamethasone) were analyzed by qPCR.
ng, ICG (indocyanine green) uptake assay, intake of acetylated low-density li-
; DiI-Ac-LDL), and Oil red O staining. MEFs and primary hepatocytes were used
, 4a1CK, 4a3CK), and primary hepatocytes cultured for 6 days. Genes that are
s are represented. The color bar at the top indicates gene expression in log2
ctively. Hierarchical clustering of the cell lines based on the gene expression
0.05; **p < 0.01; ***p < 0.001.
Figure 4. Engraftment of Donor Cells and Host Tissue Regeneration in Injured Liver after Injection of iHeps
4a3, 4a1CK, and 4a3CK iHep cells were labeled with GFP and transplanted into immunodeficient nude BALB/c mice (n = 9 for each group) that were intoxicated
with CCl4 1 day before transplantation.
(legend continued on next page)
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two inhibitors on 4a3-transduced MEFs, we could also observe
the activation of endogenous CK (Figure S5C). These data indi-
cate that the role of CK during the early phase of hepatic conver-
sion is to both inhibit the TGFb pathway and activate Wnt
signaling; thus, the treatment of two inhibitors may replace the
role of CK in the iHep generation.
Next, we counted the number of epithelial colonies on day 7
post-infection of 4a1 and 4a3 in the presence of A, CHIR99021
(R), or a combination of these inhibitors (AR) (Figures 5A and
5B). Only very few epithelial colonies were observed in trans-
duced cells without the small molecules. In contrast, a signifi-
cantly increased number of colonies was observed in the
presence of either A or AR, although the efficiency was lower
than that with 4a1CK or 4a3CK (Figure 5A). Similarly, immunoflu-
orescence analysis on day 15 showed significantly increased
E-cadherin–positive colonies in the presence of either A or AR
compared with 4a1 or 4a3 (Figures 5C and 5D). We also found
that the numbers of Alb- or Aat-positive cells were significantly
increased in the presence of AR (Figure 5E). Notably, we were
unable to observe any significant increases in the number of col-
onies in the presence of CHIR99021 alone (Figures 5A and 5C).
Moreover, we did not observe any synergistic effect between A
and R in the iHep generation (Figures 5A and 5C).
We further investigated the effect of the smallmolecules during
the early phase of hepatic conversion process by qPCR and
observed the significantly shortened conversion kinetics in the
presence of small molecules. Interestingly, according to gene
expression profiles, combined treatment with the two inhibitors
showed accelerated kinetics of fibroblast, MET, and hepatic pro-
gramscomparedwith single-inhibitor treatment (FiguresS5Eand
S5F). For instance, the expression of Cldn2 and Ttr was not fully
activated with either 4a1A or 4a3A. However, when both small
molecules were included, both genes became further activated
to levels similar to thoseof 4a1CKand4a3CK. Thus, the inhibitors
exert clear combinatorial effects in terms of gene expression dy-
namics, although their combined treatment did not lead to an
increased number of iHeps compared with single treatment (Fig-
ures S5E and S5F). This approach of combining two hepatic cell
factors together with the small-molecule-based inhibitors of
Gsk-3b and Smad signaling resulted in the efficient conversion
of MEFs into iHeps. Hence, this direct conversion cocktail could
eliminate the use of CK for the robust iHep generation.
Small Molecules Facilitate Conversion of Human
Fibroblasts into iHeps
There have been a few studies describing the generation of hu-
man iHeps (hiHeps) using different sets of transcription factors
(Du et al., 2014; Huang et al., 2014). Thus, we next investigated
whether our small-molecule cocktails could also improve upon(A) H&E staining of liver sections 3 days following transplantation of iHeps (4a3, 4a
(B–F) Immunohistochemical staining of liver sections using antibodies against Alb
(C), a-SMA (D), F4/80 (E), and fibrin (F).
(G) Quantitation of host cell proliferation by counting GFP-negative and EdU (5-e
(H and I) Serum AST (H) and ALT (I) levels on day 3 after cell grafting.
(J) Cumulative survival blot of FRGmice after transplantation of iHeps (4a3 and 4a
(trifluoromethyl)benzoyl]cyclohexane-1,3-dione [NTBC]) and untreated (-NTBC) a
Scale bars represent 100 mm in (A–E) and 200 mm in (F). Error bars indicate the S
822 Cell Reports 15, 814–829, April 26, 2016the generation of hiHeps. For this, we transduced human fetal fi-
broblasts (HFFs) with HNF4A, HNF1A, FOXA3, and SV40LT in
the presence or absence of AR. In the absence of AR, we
observed the first human iHep transduced with SV40 large T
antigen (hiHepLT) colony 6 days after transduction. In contrast,
hiHepsLT were readily observed on day 4 of transduction in the
presence of AR (Figure S6A). Interestingly, in the presence of
AR, we observed hiHeps within 6 days, even in the absence
of SV40LT (Figure S6A). However, the hiHeps were rarely
observed, even 2 weeks after transduction, in the absence of
both AR and SV40LT (data not shown), as in the previous study
(Huang et al., 2014).
To better determine the conversion efficiency into hiHeps, we
stained hiHeps for ALB and AAT on day 6 after transduction and
performed fluorescence-activated cell sorting (FACS) analysis.
As expected, we got consistently increased numbers of both
ALB- and AAT-positive cells with AR (Figure S6B). A similar in-
crease in the number of hiHeps was also observed even when
using human adult fibroblasts (HAFs) (Figure S6C) with signifi-
cantly shortened conversion kinetics in the presence of AR (Fig-
ure S6D). Established hiHepsLT exhibited hepatic morphology,
marker expression, and in vitro functionality (Figures S6E–
S6H). Our data indicate that our small-molecule cocktails facili-
tate the efficient direct conversion of human fibroblasts into
hiHeps by accelerating the conversion kinetics.
Hnf1a Alone Is Sufficient for iHep Generation in the
Presence of Small Molecules
Given that we observed the efficient hepatic conversion using
either CK or small molecules, we next investigated whether our
reprogramming condition could reduce the number of transcrip-
tion factors required for the iHep generation. For this, we first
transduced the single hepatic factors with CK and performed
FACS analysis using an antibody against E-cadherin after
14 days of infection (Figure 6A). To our surprise, each single
factor could produce E-cadherin-positive cells with variable effi-
ciency in the presence of CK. After serial passaging, we estab-
lished stable iHep lines from each condition with the typical
iHep morphology (data not shown). Although the conversion ef-
ficiency using Foxa1 or Foxa3 is significantly higher than that of
Hnf4a, iHep lines from Foxa1, Foxa3, and Gata4 did not show
proper activation of hepatocyte markers (Figure 6B). In contrast,
iHep lines from Hnf1a and Hnf4a exhibited the activation of he-
patocyte markers (Figure 6B), indicating that the single hepatic
factors such as Hnf1a and Hnf4a are sufficient for inducing he-
patic lineage conversion in the presence of CK.
Given that small molecules could replace CK in the iHep
generation (Figure 5), we next tested whether Hnf1a or Hnf4a,
with our small molecules, could sufficiently generate the1CK, and 4a3CK). Sham-operated mice received an equal volume of medium.
(ALB) and GFP (B; cells coexpressing ALB and GFP appear in yellow), PECAM
thynyl-20-deoxyuridine)-positive cells 3 days after grafting iHeps.
3CK) and primary hepatocytes in comparison with drug-treated (+2-[2-nitro-4-
nimals.
D of triplicate values. *p < 0.05.
Figure 5. Small Molecules Can Replace CK
(A and B) The number (A) andmorphology (B) of epithelial colonies after transduction of 4a1 or 4a3 in the presence of small molecules (4a1: 0.4 ± 0.5; 4a1A: 13.6 ±
4.6; 4a1R: 2.0 ± 0.7; 4a1AR: 10.6 ± 3.2; 4a1CK: 48.2 ± 20.1; 4a3: 0.5 ± 0.6; 4a3A: 20.6 ± 9.5; 4a3R: 4.4 ± 1.1; 4a3AR: 28.4 ± 16.5; 4a3CK: 56.4 ± 23.6). The
number of epithelial colonies was counted on day 7 after transduction. n = 5; error bars indicate the SD of the values. CHIR, CHIR99021. Scale bars represent
100 mm. *p < 0.05, **p < 0.01, ***p < 0.001. TF, transcription factors.
(C and D) The number (C) and morphology (D) of E-cadherin-positive colonies on day 15 after transduction (4a1: 6.0 ± 3.5; 4a1A: 46.3 ± 8.5; 4a1R: 8.6 ± 2.1;
4a1AR: 64.3 ± 29.3; 4a1CK: 319 ± 43.7; 4a3: 32.0 ± 33.9, 4a3A: 256.3 ± 89.2; 4a3R: 60.5 ± 8.4; 4a3AR: 302.5 ± 105.2; 4a3CK: 677.3 ± 91.0). Error bars indicate
the SD of triplicate values. Scale bars represent 100 mm. *p < 0.05, **p < 0.01, ***p < 0.001.
(E) The conversion efficiency into iHeps was determined by FACS analysis using antibody against Alb or Aat on day 15 of transduction. SSC, side scatter.iHeps. To this end, we cultured the single-factor-transduced
MEFs in hepatocyte culture medium containing AR. While
Hnf1a-transduced MEFs produced 14.5% of E-cadherin-
positive cells, Hnf4a-transduced MEFs showed only 1.4% ofthe E-cadherin-positive population (Figure 6C). The E-cad-
herin-positive population sorted from Hnf1a-transduced cells
readily became expandable iHep-like cells, with the typical
morphology (Figure 6D). In contrast, E-cadherin-positive cellsCell Reports 15, 814–829, April 26, 2016 823
Figure 6. Hnf1a Alone Is Sufficient for iHep Generation
(A) The conversion efficiency into iHeps using different single hepatic factors with CK was determined by FACS using antibody against E-cadherin on day 14 of
transduction.
(B) Gene expression pattern of single hepatic factors plus CK-derived iHep lines by RT-PCR. Gapdh was used as a positive control.
(C) The efficiency of hiHep generation was evaluated by FACS using antibody against E-cadherin on 5 weeks after transduction.
(legend continued on next page)
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from Hnf4a-transduced MEFs failed to form epithelial mor-
phology but showed a fibroblast-like morphology (Figure 6D),
indicating that Hnf1a, but not Hnf4a, has a strong potential for
generating iHeps in the presence of AR.
Next, we analyzed the gene expression patterns of the Hnf1a-
derived iHep-like cells (hereinafter referred as 1a iHep-like cells).
They showed complete suppression of fibroblast markers but
displayed a poor activation of mature hepatocyte markers,
such as Alb, Aat, Mrp2, Mrp3, MaoB, and Mgst1 (Figure 6G). In
the line with our expression profiling, we were unable to observe
either an Alb- or an Aat-positive population by FACS (Figure 6F),
indicating that AR supplementation is not sufficient to fully
replace the role of CK in single Hnf1a-mediated iHep generation
and, therefore, additional small molecules or growth factors may
be required for the functional maturation.
Previously, it has been described that bone morphogenetic
protein 4 (BMP4) is critical for the specification and morphogen-
esis of liver (Lammert et al., 2003).Moreover, BMP4 is also known
to induce expression of mature hepatocyte markers, including
Alb, during hepatic differentiation of embryonic stem cells
(ESCs) (Gouon-Evans et al., 2006). Thus, we again introduced
Hnf1a on MEFs in the presence of AR plus BMP4 (hereinafter
referred as ARB). We generated Hnf1a-derived iHep (hereinafter
referred as 1a iHeps) using ARBwith slightly increased efficiency
than AR only (Figures 6C and 6E), and then we analyzed the
expression patterns of functional markers. Surprisingly, ARB-
treated 1a iHeps exhibited the activation of mature hepatocyte
markers, including Alb, Aat, Mrp2, Mrp3, MaoB, and Mgst1,
which were not expressed in 1a iHep-like cells generated in the
absence of BMP4 (Figure 6G). FACS analysis also described
that Alb- or Aat-positive populations were also dramatically
increased in the presence of BMP4 (Figure 6F), indicating that
BMP4 is critical for the functional maturation of 1a iHeps.
Next, we tested whether all the small molecules, including
BMP4, are essentially required for maintaining hepatic features
after conversion into iHeps. To this end, wewithdrew all the small
molecules and analyzed both the in vitro and the in vivo function-
ality of 1a iHeps (Figure S7). Even after the withdrawal of ARB, 1a
iHeps remained E-cadherin-positive without losing normal
karyotype and other in vitro functional features (Figures S7A–
S7H). The global transcriptome of 1a iHeps without ARB is indis-
tinguishable from that of 1a iHeps with ARB (Figure S7I). Finally,
we found that 1a iHeps could prolong the survival of transplanted
FRGmice (Figure S7J). Taken together, our data suggest that the
single hepatic factor, Hnf1a, is sufficient to generate the func-
tionally mature iHeps.
Hnf1a-Derived iHeps Represent the More Mature
Hepatic State
In order to evaluate the reprogramming status of 1a iHeps, we
carefully compared 1a iHeps with 4a3 iHeps. To this end, we first(D) The morphology of FACS-sorted E-cadherin-positive from either Hnf4a- or
represent 100 mm.
(E and F) The percentage of E-cadherin- (E), Alb-, or Aat-positive cells (F) cultu
analyzed by FACS after 5 weeks of transducing Hnf1a.
(G) Gene expression pattern of 1a iHeps generated in the absence or presence o
See also Figure S7A.compared the global transcriptome of 4a3 and 1a iHeps by mi-
croarray analysis. To our surprise, 1a iHeps exhibit the dramati-
cally improved gene expression pattern compared to 4a3 iHeps
(Figure 7A). Indeed, 1a iHeps were closely clustered with primary
hepatocytes. However, 4a3 iHeps were rather clustered with the
starting MEFs. 1a iHeps also displayed an improved expression
pattern of different marker sets (Figure 7B). Gene ontology (GO)
analysis again revealed that the genes involved in various
hepatic functions such as steroid metabolic process, lipid
biosynthetic process, xenobiotic metabolic process, and bile
acid metabolic process were highly enriched in 1a iHeps
compared with 4a3 iHeps (Figure S7K). In contrast, immune-
related genes were highly activated in 4a3 iHeps. Moreover, a
qPCR analysis also showed that 1a iHeps express higher levels
of mature hepatic markers than 4a3 iHeps (Figure 7C). On the
other hand, the expression level of Afp, an immature hepatic
marker, was lower in 1a iHeps compared with 4a3 iHeps. Taken
together, these data indicate that 1a iHeps are superior to 4a3
iHeps in terms of the gene expression pattern.
Next, we compared the in vitro functionality of two iHep lines.
First, 1a iHeps displayed the higher expression levels of Cyp450
compared with 4a3 iHeps (Figure 7D). 1a iHeps also showed the
higher levels of serum Alb compared with 4a3 iHeps, although
the levels of urea synthesis look similar between two lines (Fig-
ures 7E and 7F). Finally, the series of in vitro functional assays
clearly show that 1a iHeps indeed outperform 4a3 iHeps (Fig-
ure 7G). Taken together, these data indicate that 1a iHeps gener-
ated by our protocol represent the more mature hepatic state
than 4a3 iHeps generated with the previously defined hepatic
factors (Sekiya and Suzuki, 2011).
DISCUSSION
In the present study, we first aimed to investigate the molecular
mechanisms governing cell-fate transition of fibroblasts into
iHeps by exploring the kinetics of the direct conversion process.
We found that the direct conversion toward iHeps is a sequential
transition involving the systematic orchestration of cellular and
molecular events: (1) the inactivation of fibroblast markers, (2)
the upregulation of MET-related genes, and (3) the activation of
hepatocyte markers (Figure 1E). To accelerate the kinetics of
both the MET and hepatic programs at the early phase of the
direct conversion process, we screened for additional fac-
tors—five hepatic factors and two MET-related genes—that
are known to play a key role in both activating liver functions
and the MET process. We observed neither faster direct conver-
sion kinetics nor improved conversion efficiency using additional
hepatic factors. However, CK dramatically enhanced the direct
hepatic reprogramming by accelerating the kinetics of the entire
direct conversion process, even at the epigenetic level. There-
fore, our results demonstrate that the MET is a critical step forHnf1a-transduced MEFs in the presence of small molecules, AR. Scale bars
red in the absence or presence of an additional small molecule, BMP4, was
f BMP4 by RT-PCR. Gapdh was used as a positive control.
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rendering hepatic cell identity on somatic cells and also that the
MET activators, CK, are the boosting factors for the lineage tran-
sition into the hepatic cell state. Beside the conversion efficiency
and kinetics, 4a3CK iHeps exhibited improved hepatic function-
ality compared to 4a3 iHeps, as evidenced by the increased
levels of Cyp450 (Figures 3D and 3E), as well as suggested by
an enhanced survival rate of FAH/ mice upon transplantation
of iHeps (Figure 4J). Furthermore, 4a3CK iHeps express rela-
tively lower levels of Afp and Dlk1, the immature hepatocyte
markers compared to those of 4a3 iHeps (Figure S1C), indicating
that 4a3CK iHeps are superior to 4a3 iHeps in terms of conver-
sion efficiency, reprogramming kinetics, and both in vitro and
in vivo functionality (Table S1).
Because of the oncogenic properties of CK, we attempted to
develop a novel reprogramming cocktail by using small mole-
cules to replace CK. As a result, we found that combined treat-
ment with A-83-01 and CHIR99021 could replace CK, given
that these two inhibitors, together with a minimal number of he-
patic factors, led to dramatically increased numbers of iHeps
with accelerated direct conversion kinetics. Notably, we were
unable to observe improved conversion efficiency in the pres-
ence of CHIR99021 alone, an inhibitor of Gsk-3b (Figures 5A
and 5C), although activating the Wnt signaling pathway could
enhance the proliferation rate of MEFs (Figure S5D) as in a pre-
vious study (Marson et al., 2008). This result suggests that
increased cell proliferation could not be a crucial element for
efficiently converting somatic cells into iHeps. In contrast, treat-
ment of fibroblasts with A-83-01 alone, together with a minimal
number of hepatic factors, could facilitate the efficient direct
conversion into iHeps. Furthermore, activating the MET with
A-83-01 could induce the rapid inactivation of fibroblast program
and accelerate the activation of both the MET and hepatic pro-
grams. Moreover, blocking the MET process by treating Tgfb1
and/or Tgfb2 at the early phase of hepatic lineage transition
completely abolished the effect of CK, indicating that the MET
process is an essential step for hepatic lineage conversion (Fig-
ures S3F–S3I). Together, our data suggest that the accelerated
kinetics and enhanced efficiency of the direct conversion pro-
cess mediated by CK are not due to the increased proliferation
of the starting cells but rather to the activated MET process.
Although previous studies have thoroughly demonstrated that
iHeps share a number of key features with primary hepatocytes,
a recent study (Morris et al., 2014) suggested that iHeps rather
represent an endoderm-progenitor-like state based on the
gene expression profiles. However, the previous study mainly
used an iHep line generated by a different hepatic combination
(Hnf4a and Foxa1) (Morris et al., 2014) from ours. In the presentFigure 7. Direct Comparison of Gene Expression Profiles and In Vitro
(A and B) Heatmaps representing the global gene expression profile (A) and th
pathways and MET process (B) of MEFs, 4a3 iHeps, 1a iHeps cultured in the ab
archical clustering of the cells based on the gene expression profiles is displaye
(C andD) Expression levels of liver-specific genes (C) andCyp450 enzymes in resp
primary hepatocytes. Error bars indicate the SD of triplicate values. *p < 0.05, **
(E and F) Alb secretion (E) and urea production (F) were determined in 4a3 and
controls, respectively. Error bars indicate the SD of triplicate values.
(G) In vitro functional analysis of iHep lines including PAS staining, ICG uptake assa
was measured. n = 5; error bars indicate the SD of values.
Scale bars represent 100 mm.study, we also realized that iHeps are not identical to primary he-
patocytes in gene expression profile (Figures S4E–S4G) and
epigenetic status (data not shown). Despite their differences,
iHep lines generated in the current and previous studies are
functionally mature, as evidenced by a series of in vitro and
in vivo assays. Therefore, it would be interesting to analyze the
multiple iHep lines generated from different combinations of he-
patic transcription factors to gain an in-depth understanding of
their reprogramming status, including the remnant epigenetic
memory of the somatic cells.
Finally, we demonstrated that Hnf1a alone is sufficient for
generating functional iHeps in the presence of A-83-01,
CHIR99021, and BMP4 and also that the single Hnf1a-derived
iHeps exhibit the more mature hepatic state compared to the
iHeps generated with the previously defined reprogramming
cocktail (Sekiya and Suzuki, 2011). Thus, we next investigated
whether our small-molecule cocktail could also facilitate
Hnf1a-derived hiHep generation. Although we could establish
the stable hiHep-like population with the typical hiHep mor-
phology and marker gene expression, the Hnf1a-derived
hiHep-like cells exhibit the relatively poor activation of hepatic
markers (data not shown). Therefore, our data suggest that our
small-molecule cocktail, together with HNF4A, HNF1A, and
FOXA3, could dramatically enhance the hiHep generation with
accelerated conversion kinetics (Figure S6), but they are not
enough for fully inducing the stable hepatic state using the single
hepatic factor,HNF1A. Inmany cases, the defined direct conver-
sion factors screened from mouse studies are insufficient for
converting human somatic cells into their targets (Du et al.,
2014; Huang et al., 2014; Ieda et al., 2010; Ifkovits et al., 2014;
Son et al., 2011; Wada et al., 2013). Together, our single hepatic
factor strategy combined with small-molecule cocktails defined
herein may facilitate the translation of iHep technology into clin-
ical applications, as a detailed elucidation of the direct conver-
sion process may pave the way to a direct conversion of fibrotic
tissue into iHep in a therapeutic in vivo approach.EXPERIMENTAL PROCEDURES
Generation of iHeps
To generate mouse iHeps, fibroblasts (5 3 104 cells) were infected with pMX
retrovirus expressing the transcription factor in different combinations for
48 hr. Cells transduced with different combinations of factors were cultured
in hepatocyte culture medium: DMEM/F-12 supplemented with 10% fetal
bovine serum (FBS) (Biowest), 0.1 mM dexamethasone (Sigma-Aldrich),
10 mM nicotinamide (Sigma), 1% ITS (insulin-transferrin-selenium) premix
(GIBCO), and penicillin/streptomycin/glutamine (Invitrogen), 10 ng/ml fibro-
blast growth factor 4 (Peprotech), and both hepatocyte growth factorFunctionality between 4a3 and 1a iHeps
e expression patterns of the selected genes involved in different metabolic
sence or presence of small molecules (ARB), and primary hepatocytes. Hier-
d on the top of the heatmaps.
onse toCyp inducers (D) by qPCR. Expression levels are normalized to those of
p < 0.01.
1a iHeps. MEFs and primary hepatocytes were used as negative and positive
y, intake of DiI-Ac-LDL, andOil RedO staining. Percentage of the positive cells
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(Peprotech) and epidermal growth factor (Peprotech) at a final concentration of
20 ng/ml on a Type-I-collagen-coated dish (Sigma-Aldrich).
Statistical Analysis
Data are reported as mean values from at least three replicates, with error bars
denoting SD. Statistical significance was evaluated with a one-way ANOVA or
unpaired two-tailed Student’s t test using Microsoft Excel.
SUPPLEMENTAL INFORMATION
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